Anzeige
Meldung des Tages: Vor der Neubewertung dank Dealfantasie? Dieser Explorer bringt sich jetzt strategisch in Position

Klotho Neurosciences News

Aktie
WKN:  A40KLP ISIN:  US49876K1034 US-Symbol:  GRML Branche:  Biotechnologie Land:  USA
0,402 $
-0,0001 $
-0,02%
0,34191 € 20.04.26
Depot/Watchlist
Marktkapitalisierung *
9,57 Mio. €
Streubesitz
76,14%
KGV
-
Index-Zuordnung
-

Klotho Neurosciences News

16.04.26 - PR Newswire
GREENLAND MINES ENTERS INTO LOI TO EVALUATE BROWNFIELD DOWNSTREAM ICELANDIC INDUSTRIAL PROCESSING SITE, OUTLINES STRATEGIC SUPPLY CHAIN SECURITY PROGRAM
GREENLAND MINES ENTERS INTO LOI TO EVALUATE BROWNFIELD DOWNSTREAM ICELANDIC INDUSTRIAL PROCESSING SITE, OUTLINES STRATEGIC SUPPLY CHAIN ...
02.04.26 - PR Newswire
Greenland Mines Subsidiary Major Precious Greenland A/S Joins Greenland Business Association
Greenland Mines Subsidiary Major Precious Greenland A/S Joins Greenland Business Association PR Newswire
25.03.26 - PR Newswire
Greenland Mines Secures Icebreaker Argus For 2026 Skaergaard Field Program
Greenland Mines Secures Icebreaker Argus For 2026 Skaergaard Field Program PR Newswire
23.03.26 - PR Newswire
Greenland Mines Secures Additional 180-Day Period for Nasdaq Bid Price Compliance
Greenland Mines Secures Additional 180-Day Period for Nasdaq Bid Price Compliance PR Newswire
19.03.26 - PR Newswire
Greenland Mines Engages WSP Denmark to Launch Comprehensive Environmental Baseline Program at Skaergaard Mining Site
Greenland Mines Engages WSP Denmark to Launch Comprehensive Environmental Baseline Program at Skaergaard Mining Site PR Newswire
12.03.26 - PR Newswire
Klotho Neurosciences Completes Rebranding to Greenland Mines Ltd and Change of Nasdaq Ticker Symbol to GRML
Klotho Neurosciences Completes Rebranding to Greenland Mines Ltd and Change of Nasdaq Ticker Symbol to GRML PR Newswire
04.03.26 - PR Newswire
KLOTHO NEUROSCIENCES ACQUIRES GREENLAND MINES CORP., SECURING CONTROL OF A $68 BILLION PALLADIUM, GOLD, PLATINUM, AND CRITICAL MINERAL DEPOSIT IN THE WORLD'S MOST STRATEGICALLY VITAL EMERGING TRADE CORRIDOR
KLOTHO NEUROSCIENCES ACQUIRES GREENLAND MINES CORP., SECURING CONTROL OF A $68 BILLION PALLADIUM, GOLD, PLATINUM, AND CRITICAL MINERAL ...
24.02.26 - PR Newswire
Klotho Neurosciences (NASDAQ:KLTO) Initiates Development of the "Klotho Clock," a Diagnostic Biological Aging and Longevity Clock that Unlocks Health Testing Through Epigenetics and Artificial Intelligence (AI)
Klotho Neurosciences (NASDAQ:KLTO) Initiates Development of the "Klotho Clock," a Diagnostic Biological Aging and Longevity Clock that Unlocks Health Testing Through ...
18.02.26 - PR Newswire
Klotho Neurosciences Receives Patent Claims in Australia for Composition and Use of Human Secreted Klotho Protein ("s-KL") Isoform of the Human Klotho Gene Sequence
Klotho Neurosciences Receives Patent Claims in Australia for Composition and Use of Human Secreted Klotho Protein ("s-KL") Isoform of the Human Klotho Gene Sequence PR ...
08.01.26 - PR Newswire
Klotho Neurosciences to Present at the Biotech Showcase 2026
Klotho Neurosciences to Present at the Biotech Showcase 2026 PR Newswire
07.11.25 - PR Newswire
Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award
Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award PR Newswire
16.10.25 - PR Newswire
Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston
Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston PR Newswire
07.10.25 - PR Newswire
Klotho Neurosciences Announces Expiration of Letter of Intent
Klotho Neurosciences Announces Expiration of Letter of Intent PR Newswire
30.09.25 - PR Newswire
Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership
Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership PR Newswire
09.09.25 - PR Newswire
CEO von Klotho Neurosciences nimmt an Eröffnungskonferenz und wissenschaftlichem Seminar teil
CEO von Klotho Neurosciences nimmt an Eröffnungskonferenz und wissenschaftlichem Seminar teil PR Newswire
08.09.25 - PR Newswire
Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar
Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar PR Newswire
08.09.25 - PR Newswire
Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar
Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar PR Newswire
18.08.25 - PR Newswire
Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market
Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market PR Newswire
12.08.25 - PR Newswire
Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene's Platform Technology
Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene's Platform Technology PR Newswire
25.07.25 - PR Newswire
UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology
UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology PR Newswire

Newssuche

Videos

newspaper
20.04.26 -0,85%
Technical Trading: GBP Long im Trend
GBP/USD Long Typ: Open End Turbo WKN: VV7A4S Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »